MAGNEVIST

LOE Approaching

gadopentetate dimeglumine

NDAINJECTIONINJECTABLE
Approved
Mar 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
11

Clinical Trials (5)

NCT01050829Phase 3Completed

Gadobutrol Magnevist-controlled Body Study

Started Jan 2010
370 enrolled
Magnetic Resonance Imaging
NCT00744939N/ACompleted

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Started Nov 2008
168 enrolled
FibrosisKidney FailureRenal Insufficiency
NCT01376739N/ACompleted

Magnevist Post-marketing Surveillance in Japan

Started Aug 2007
2,051 enrolled
Diagnostic Imaging
NCT00486473Phase 3Completed

Multihance Versus Magnevist in Breast MRI

Started Jul 2007
130 enrolled
Breast Cancer
NCT00652418Phase 2Completed

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography

Started Jul 2004
12 enrolled
Magnetic Resonance AngiographyPeripheral Vascular DiseasesPeripheral Arterial Diseases